Catalent's average Accounts Receivable for the
three
months ended in Dec. 2023 was $837 Mil. Catalent's Revenue for the
three
months ended in Dec. 2023 was $1,024 Mil.
Hence, Catalent's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 74.54.
The historical rank and industry rank for Catalent's Days Sales Outstanding or its related term are showing as below:
CTLT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.06 Med: 78.93 Max: 90.52
Current: 82.65
During the past 13 years, Catalent's highest Days Sales Outstanding was 90.52. The lowest was 76.06. And the median was 78.93.
CTLT's Days Sales Outstanding is ranked worse than 61.3% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 71.68
vs CTLT: 82.65
Catalent's Days Sales Outstanding
declined
from Dec. 2022 (75.64) to Dec. 2023 (74.54).
Catalent Days Sales Outstanding Historical Data
The historical data trend for Catalent's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catalent's Days Sales Outstanding
For the Drug Manufacturers - Specialty & Generic subindustry, Catalent's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catalent's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Catalent's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Catalent's Days Sales Outstanding falls into.
Catalent Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catalent (NYSE:CTLT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Catalent Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Catalent's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTLT has been successfully added to your 